Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Overexpression of eukaryotic initiation factor 4E (eIF4E) promotes cell transformation and is implicated in human cancers.
• eIF4E availability regulates mRNA translation and cell growth by forming initiation complexes with eIF4G.
• eIF4E-binding proteins (4E-BPs) inhibit eIF4E availability, and their overexpression can reverse eIF4E-induced cell transformation.

Purpose of the Study:

• To investigate the role of eIF4E in cell transformation using novel peptide inhibitors.
• To explore the mechanism by which eIF4E influences cell survival and apoptosis.

Main Methods:

• Development of peptides mimicking eIF4E-binding motifs from 4E-BPs and eIF4G, linked to a cell-penetrating sequence.
• Introduction of these peptides into MRC5 cells to observe effects on cell viability and apoptosis.
• Site-directed mutagenesis (alanine substitutions) to assess the importance of eIF4E binding for peptide activity.

Main Results:

• Peptides designed to bind eIF4E induced rapid, dose-dependent apoptosis in MRC5 cells.
• Alanine substitutions impairing eIF4E binding significantly reduced the apoptotic effect.
• A peptide with abolished eIF4E binding failed to induce apoptosis, confirming eIF4E binding as the mechanism.
• Apoptosis induction was independent of protein synthesis inhibition.

Conclusions:

• The study demonstrates that eIF4E plays a direct role in promoting cell survival.
• This pro-survival role of eIF4E is distinct from its established function in mRNA translation.
• Targeting eIF4E with specific peptides represents a potential therapeutic strategy for cancers associated with eIF4E overexpression.